comparemela.com
Latest Breaking News On - Susanne stowasser - Page 1 : comparemela.com
New data from Boehringer Ingelheim support the potential use of nintedanib in children and adolescents with fibrosing interstitial lung disease
InPedILD Phase III trial showed encouraging results for both primary endpoints. Full data were published in the European Respiratory Journal and presented at.
Colorado
United-states
Germany
Spain
Barcelona
Comunidad-autonoma-de-cataluna
Kerry-wycislo
Robin-deterding
Boehringer-ingelheim
Susanne-stowasser
Boehringer-ingelheim-pharmaceuticals
Boehringer-ingelheim-pharmaceuticals-inc
vimarsana © 2020. All Rights Reserved.